News | May 26, 2022
Strides Pharma Science Q4FY22 consolidated PAT at Rs. 29.21 Cr
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
Five patient-first principles to provide the highest standard of healthcare
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The new IGX-Track App adds seamless analysis of antibody panning campaigns to the IGX Platform
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
Successfully removed peanut from the child’s left lung through bronchoscopy
Subscribe To Our Newsletter & Stay Updated
